Is Ephedrine legal in Belgium?

Legal status

Ephedrine is controlled in Belgium as a drug precursor rather than under Annexes I to IV of the Royal Decree of 6 September 2017. It is a category 1 scheduled substance in Annex I to Regulation (EC) No 273/2004 as amended, which applies in Belgium as EU law, and medicinal products containing ephedrine are addressed separately by the precursor framework and by the Belgian medicines rules. That is a different instrument from the delegated controlled drug list, and the difference matters: Belgium works a delegated model: article 2bis §1 of the Law of 24 February 1921 punishes breaches concerning substances whose list is settled by the King, and the Royal Decree of 6 September 2017 supplies that list. The named lists are closed, so pharmacological resemblance, a similar spelling or a substring match cannot enlarge them. The precursor route regulates trade, record keeping and reporting rather than placing the substance on the narcotic or psychotropic annexes.

Consequences if caught

Capital exposure: none. Belgium's drug law carries no death penalty and no life sentence. No ceiling under article 2bis of the Law of 24 February 1921 is assigned from the EU precursor entry alone. The applicable Belgian precursor offence and the actual product facts would have to be identified first, and this row does not identify them. A category 1 listing is a controls and licensing regime for trade in a scheduled chemical, and reading a twenty year drug ceiling straight off it would be an error of instrument. Where a particular consignment or preparation turns out to engage the controlled drug annexes instead, that would be a different finding from this one and would carry its own route.

If prescribed or medical

The rule that applies to a traveller here is Belgium's own and it is one rule for the whole country: article 3(4)(4) of the Royal Decree of 6 September 2017. It is a document exception rather than a schedule, and it is not a prescribing right. It covers a medicine that was lawfully obtained, carried for the traveller's own personal use, and limited to no more than three months of treatment, and it expressly excludes the substances in Annex II limb A. Ephedrine is not in Annexes I to IV at all, so there is nothing here for the exception to except, and a traveller question about an ephedrine containing medicine is a medicines and precursor question rather than a controlled drug one. The precursor framework addresses medicinal products containing ephedrine separately, and that is a supply chain rule rather than a patient carriage rule. No route specific to ephedrine was found in this dossier and none has been invented for it.

Documentation

Carry the prescription and the original dispensing packaging for any ephedrine containing medicine, and treat quantities beyond personal treatment as a precursor question rather than a drug schedule one. The category 1 listing in Annex I to Regulation (EC) No 273/2004 as amended was read on 18 September 2026. The annex consolidation relied on here is valid from 29 March 2026, following the amending Royal Decree published on 19 March 2026, and carries a correction dated 16 July 2026.

Drug laws and enforcement change and vary within a country. This is not legal advice. Always confirm with Belgium’s embassy or official drug authority before traveling; penalties can be severe, including imprisonment.